Figure 5
Figure 5. SOCS3 regulates mitogenic signaling cascade in Treg in response to SAA. (A left) Percentages of proliferating Treg and Teff in suppression assays with HC plasma (n = 5) and SJIA plasma (n = 5). (Right) Percentages of proliferating forskolin-treated Treg and untreated Teff in suppression assays with HC plasma (n = 5) and SJIA plasma (n = 5). Treg were rested in complete media or treated with forskolin for 24 hours before being used in these assays. (B left) Effects of Treg specific-SOCS3 modulation on phosphorylation status of ERK1/2 and AKT by Treg and Teff in suppression assays. Data were collected at day 4 during suppression assays with SJIA plasma (n = 6), HC plasma (n = 6) or complete media (FBS, n = 4). (Right) Representative FACS plots of pERK1/2 and pAKT in Treg and Teff in suppression assays. Unpaired 2-tailed t tests (A,C,D) and paired 2-tailed t tests (B) were used for statistical analyses. Horizontal bars represented median values.

SOCS3 regulates mitogenic signaling cascade in Treg in response to SAA. (A left) Percentages of proliferating Treg and Teff in suppression assays with HC plasma (n = 5) and SJIA plasma (n = 5). (Right) Percentages of proliferating forskolin-treated Treg and untreated Teff in suppression assays with HC plasma (n = 5) and SJIA plasma (n = 5). Treg were rested in complete media or treated with forskolin for 24 hours before being used in these assays. (B left) Effects of Treg specific-SOCS3 modulation on phosphorylation status of ERK1/2 and AKT by Treg and Teff in suppression assays. Data were collected at day 4 during suppression assays with SJIA plasma (n = 6), HC plasma (n = 6) or complete media (FBS, n = 4). (Right) Representative FACS plots of pERK1/2 and pAKT in Treg and Teff in suppression assays. Unpaired 2-tailed t tests (A,C,D) and paired 2-tailed t tests (B) were used for statistical analyses. Horizontal bars represented median values.

Close Modal

or Create an Account

Close Modal
Close Modal